Fully 26% of study participants with moderate to severe COVID-19 symptoms reported frequent pain, researchers report.
With the exception of duloxetine, there is not enough reliable evidence to support the use of most antidepressant medications in the relief of chronic pain, a new review and meta-analysis has shown.
In the U.S., new cases of chronic pain occur more often than new cases of other common health conditions. This pain is also persistent, lasting at least one year for most people, investigators report.
An estimated 21% of U.S. adults experienced chronic pain in 2021, and 7% reported chronic pain that restricts their daily activities, according to a new analysis.
Patients’ daily opioid doses were reduced by up to 51% of baseline 8 months after receiving a medical cannabis prescription, researchers found.
Share of adults with long COVID symptoms declining … FDA approves new drug Leqembi to treat early Alzheimer’s disease … 1 in 4 adults with chronic pain trying cannabis for relief
Stroke survivors with chronic pain may perceive that their stroke-affected hand is a different size, giving therapists a new target for rehabilitation, researchers say.
Most American adults use alternatives to opioid drugs such as complementary medicine to manage their pain, but psychological therapies are infrequently implemented, researchers say.
EaseVRx is designed for home use and is available by prescription to patients with clinically diagnosed lower back conditions, FDA says.
Group-based CBT intervention produced modest, but sustained, reductions in measures of pain, pain-related disability
Please login or register first to view this content.